The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform

The development of resources for clinical interpretation of cancer-associated genetic alterations has significantly lagged behind the technical developments enabling their detection in a time-and cost-efficient manner. The lack of scientific and informatics decision support for oncologists can lead...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drug Discov Today
Asıl Yazarlar: Johnson, Amber M., Zeng, Jia, Bailey, Ann M., Holla, Vijaykumar, Litzenburger, Beate, Lara-Guerra, Humberto, Mills, Gordon B., Mendelsohn, John, Shaw, Kenna R., Meric-Bernstam, Funda
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648066/
https://ncbi.nlm.nih.gov/pubmed/26148707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2015.05.013
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller